IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Artelo Biosciences Inc (ARTL)

CUSIP: 04301G607 | NYSE | Healthcare · Biotechnology | Micro Cap | 17 institutional holders

Quarters

Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/AFarb Daniel Stuart16,3990.8%−136,604Oct 20, 2025No 13F filer matched
13D/AFarb Daniel Stuart16,399
0.8% of class · Oct 20, 2025

Institutional Holders — Q1 2026

Altshuler Shaham Ltd889
0.0% of portfolio›$484.2K
Vanguard Group Inc0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Altshuler Shaham Ltd
889$484.2K0.0%CoreHighTel Aviv, Luxembourg2026-05-18
Vanguard Group Inc
0$00.0%N/AN/AValley Forge, PA2026-05-14
−136,604
No 13F filer matched